Are the "Cardiac Benefits" of Empagliflozin Independent of Its Hypoglycemic Activity? (ATRU-4).
Clinical trial NCT03485222 · COMPLETED
Trial details
- NCT number
- NCT03485222
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2020-02-13
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.